This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview
Vliek, Sonja

Sonja Vliek

Ph.D. Student


I'm a medical oncologist in training and PhD student since 2016. I coordinate the SUBITO-trial, which compares Intensified Alkylating  chemotherapy to conventional therapy added with one year PARPi (olaparib) in stage III HER2-negative BRCA1-like breast cancer (BC) and the ABC-trial which evaluates the potential efficacy of PARPi (niraparib) in metastatic BRCA1-like BC.

Secondly I'm involved in the neoTN trial (Intensified Alkylating  chemotherapy in BRCA1-like BC), TEAM IIB trial (adjuvant bisphosphonates in postmenopausal women with ER+ early BC), RASTER (observational trial concerning the MammaPrint in early BC) and follow-up and additional analysis of the IKA-tamoxifen trial.